Industry Insights
The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.
According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S. In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.
Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD. ECMO machines are gaining popularity in the hospital and healthcare systems due to the rising trend of its application during cases of respiratory disorders.
The ECMO machines are used in cases of cardiac failure to facilitate auxiliary oxygen support system. These machines are frequently used in patients suffering from respiratory conditions and also in neonates and pediatric patients. The estimated growth of these machines can be attributed to the critical nature of the target population consisting of neonates and pediatric patients.
Get Exclusive Free Sample Copy Of This Report @ https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market/request-sample
Modality Insights
The segmentation of the key modalities is done on the basis of the different setups that are provided by the ECMO circuit such as arterio-venous, veno-arterial and veno-venous. They are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.
Both gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system. It majorly works by passing the blood flow from the patients’ heart and lungs to the ECMO circuit. The veno-venous ECMO system on the other hand facilitates sole gas exchange support in which the blood is made to return to the heart prior to pulmonary circulation. According to the U.S. National Institute of Health (NIH), combination of veno-venous and veno-arterial is used in specific cases such as cardiogenic shock.
Applications Insights
As per applications, the market is segmented into Extracorporeal Cardiopulmonary Resuscitation (ECPR), respiratory and cardiac. The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric. The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.
The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders. As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.
Regional Insights
The major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA. North America has grown considerably in this segment majorly attributed to the well developed primary, secondary and tertiary care hospitals combined with the reimbursement network, increasing awareness about the ECMO system facilitating their rapid adoption in the hospitals and favorable government funding.
Refinements in the technology presently in use was made by Terumo Cardiovascular Systems Corporation during the production of CAPIOX FX Oxygenator. This system is expected tohelp in increasing the blood rate and offer complete control over the entire process.
Competitive Market Share Insights
Some key players operating in the ECMO market include MAQUET Holding B. V. & Co. KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation. The major strategic initiatives adopted by the companies in this vertical are technological advancements in the existing portfolio and new product development.
For example, Medtronic Plc designed Minimax Plus Oxygen System for patients from wide ranging age groups such as from neonates to children, with features such as venous air director and low arterial port, which are integrated in the system to increase the safety levels and performance.
Browse Complete Report Summary with TOC here https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email:[email protected]
Industry InsightsThe global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.Regional InsightsThe major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA.
Jan 22, 2021: Industry InsightsThe global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.Regional InsightsThe major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA.
The global neckwear market size is expected to register revenue of USD 4.2 Billion by the end of 2025, according to a new report by Million Insights.
Thus, key players in this market focus on product development and innovation to launch a variety of products based on patterns, colors, designs, and materials.
The segment of the self-tied wearing type held the largest share across the global market, in 2018 owing to its feature of convenience of wearing.
Moreover, the pre-tied neckwear segment is anticipated to register the highest CAGR of 2.7% from 2019 to 2025 due to its time-saving feature and ease of wearing.
Moreover, rising number of professionals like students, bankers, and hotel employees is anticipated to pave way for the demand for neckties during the forecasted years, 2019 to 2025.
The bow ties segment is anticipated to register the highest CAGR in the upcoming years.
Rising acceptance, particularly in Latin America, Asia Pacific, and the Middle East, are anticipated to drive the growth of the market.
Numerous benefits together with longer stability along with reliability are also expected to help the growth of the industry over the coming yearsGrowing disposable income of the consumer, predominantly in countries such as China, Brazil along with India coupled with the increasing need for faster transportation facilities may elevate the demand for the elevator.
The elevator industry is hovering for growth owing to superior control of elevator traffic and the growing requirement for improved energy efficiency worldwide.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/smart-elevator-marketExpansion of products that utilize renewable energy sources is likely to offer new development avenues in the upcoming years.
Extensive usage in different sector like industrial, commercial as well as residential areas is further liable to drive the growth of the market.
Elevator access control & security market helped in accounting more than 35% of the overall share in 2014, but this proportion may decrease over the coming years.Maintenance segment is estimated to demonstrate considerable development in upcoming few years which may credit to increasing maintenance related activities of already installed products in mature markets such as North America along with Europe.Application InsightsResidential segment has for over 20% of the total revenue share in 2014 which is anticipated to rise over the forecast period.
Industrial segment is probable to appear as the fastest growing application in next few years owing to the mounting demand for energy-efficient solutions which results in increasing acceptance.The commercial segment may observe significant development over the given forecast period due to advantages such as reduced operational cost, low power consumption, and cost savings.View Full Report with TOC @ https://www.millioninsights.com/industry-reports/smart-elevator-market/request-sampleRegional InsightsIn 2014 North America smart elevator market was a leading regional segment as well as accounted for more than 40% of the revenue.
Global chelating agents market is expected to reach USD 5.17 billion by 2024.
Chelating agents are also termed as sequestering, chelants or chelators agents; which are chemical compounds that react with metal ions to form water-soluble, stable metal complexes.
The chelating agent market is estimated to grow at a significant CAGR of 3.1% over the forecast period as the scope and its applications are rising enormously across the globe.The factors that are playing a major role in the growth of chelating agents market are rising awareness regarding water treatment, growing use of biodegradable chelating agents, and high demand from end users like cleaners & detergents.
However, ecotoxicological risk regarding conventional chelating agents may restrain overall market growth in the years to come.
The other sector comprises N-(2-Hydroxyethyl) ethylenediaminetetraacetic acid (HEDTA), zeolites, and biodegradable chelating agents.
In addition, phosphates & phosphonates sector is estimated to grow at the fastest pace in the years to come.The market may be categorized based on applications like food & beverage, cleaners, pharmaceutical, water treatment, personal care, pulp & paper, agrochemicals, and others.
19 February 2020 - The global Gene Expression Market is estimated to reach USD 11.3 billion by 2025.
Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development.
In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines.
However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry.The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes.
The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/gene-expression-analysis-marketIn context with the consumables of gene expressions, the industry is classified into DNA chips and reagents.
Aforementioned factor would drive the demand for profiling services over the forecast period.The genetic code expression includes translation and transcription process.
